Directory
Xavier Matias-Guiu Guia

Xavier Matias-Guiu Guia

Degree: PhD

973 705 340
fjmatiasguiu.lleida.ics(ELIMINAR)@gencat.cat

ResearcherID: http://www.researcherid.com/rid/C-3039-2009

Publications

  • Cuatrecasas, M; MATIASGUIU, X; Prat, J

    Synchronous mucinous tumors of the appendix and the ovary associated with pseudomyxoma peritonei - a clinicopathologic study of six cases with comparative analysis of c-Ki-ras mutations

    AMERICAN JOURNAL OF SURGICAL PATHOLOGY 20 739-746. .

    [doi:10.1097/00000478-199606000-00012]

  • Berna, L; Caixas, A; Piera, J; Gomez, G; MATIASGUIU, X; Estorch, M; Puig, M; Carrio, I

    Technetium-99m-methoxyisobutylisonitrile in Localization of ectopic parathyroid adenoma

    Journal Of Nuclear Medicine 37 631-633. .

  • Capella, G; MATIASGUIU, X; Ampudia, X; deLeiva, A; Perucho, M; Prat, J

    Ras oncogene mutations in thyroid tumors - Polymerase chain reaction-restriction-fragment-length polymorphism analysis from paraffin-embedded tissues

    Diagnostic Molecular Pathology 5 45-52. .

    [doi:10.1097/00019606-199603000-00008]

  • Sole, JM; Guedea, F; MATIASGUIU, X; Lerma, E; Seral, A

    Long-term risk of sarcoma following radiation treatment for breast cancer

    ONCOL REP 3 397-399. .

  • Chico, A; Pallares, MC; MATIASGUIU, X; Cipres, L; PuigDomingo, M; Webb, SM

    Bronchial carcinoid tumor presenting as a thyroid nodule: an unusual clinical manifestation

    Journal Of Endocrinological Investigation 19 186-189. .

  • Hidalgo, L; Villanueva, A; Soler, T; Guiu, XM; Capella, G

    Molecular alterations in adenocarcinoma of small bowel associated with Peutz-Jeghers syndrome.

    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS 88 137-140. .

  • Alejo, M; Margall, N; MATIASGUIU, X; Esteva, E; Lerma, E; Coll, P; Prat, J

    DNa-ploidy and HPV infection in epithelial lesions of the lower female genital tract

    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER 6 1-7. .

    [doi:10.1046/j.1525-1438.1996.06010001.x]

  • Colomer, A; MartinezMas, JV; MATIASGUIU, X; Llorens, A; Cabezas, R; Prat, J; GarciaAmeijeiras, A

    Sex-steroid hormone receptors in human medullary thyroid carcinoma

    Modern Pathology 9 68-72. .

  • Komminoth, P; MulettaFeurer, S; Saremaslani, P; Seelentag, WKF; Kunz, EK; Hiort, O; MATIASGUIU, X; Roth, J; Heitz, PU

    RET proto-oncogene point mutations in sporadic neuroendocrine tumors

    LABORATORY INVESTIGATION 74 270-270. .

  • Costa, I; Colomer, A; Lerma, E; MATIASGUIU, X; Prat, J

    Prognostic factors in stage I ovarian cancer

    LABORATORY INVESTIGATION 74 509-509. .

  • MATIASGUIU, X

    Biotin-rich nuclear inclusions of gestational endometrium, not herpes infection

    PATHOL RES PRACT 191 1271-1272. .

  • KOMMINOTH, P; MULETTAFEURER, S; SAREMASLANI, P; KUNZ, EK; MATIASGUIU, X; HIORT, O; SCHRODER, S; SEELENTAG, WKF; ROTH, J; HEITZ, PU

    MOLECULaR DIaGNOSIS OF MULTIPLE ENDOCRINE NEOPLaSIa (MEN) IN PaRaFFIN-EMBEDDED SPECIMENS

    ENDOCRINE PATHOLOGY 6 267-278. .

    [doi:10.1007/BF02738727]

Projects

  • Homologous recombination deficiency in high-grade endometrial cancers. Biomarkers and impact of intratumor heterogeneity.
  • EPH Receptor Signaling in Endometrial Cancer
  • Ajuts per a la contractació de personal investigador novell (FI)
  • Personalized Immunotherapy for Endometrial Cancer; Acronym: ExCITE (Endometrial Cancer Immunotherapy)
  • "Multi-Omics data for Cancer Research and the Development of New Diagnostics and Therapies"
  • EFFICACY: Nuevas estrategias para incrementar efectividad de los tratamientos con ABTL0812
  • Incorporación de nuevas areas temáticas y nuevos grupos al consorcio CIBER
  • Perfiles epigenéticos asociados a patrones de metastasis en cáncer de endometrio
  • CONTRACTES D'INCORPORACIO DE CIENTIFICS I TECNOLEGS: INCORPORACIO D'UNA DOCTORA PER A L'ACCIO ANTITUMORAL DELS CANNABINOIDES EN EL CARCINOMA D'ENDOMETRI
  • DISCOVERY, VALIDATION AND IMPLEMENTATION OF BIOMARKERS FOR PRECISION ONCOLOGY
  • Desarrollo de nuevas aproximaciones en el manejo individualizado de pacientes con cancer ginecológico (PREDICTGYN)
  • VALIDACION DE ANEXINA 2 COMO PREDICTOR DE RECIDIVA EN EL CANCER DE ENDOMETRIO. DISEÑO DE NUEVAS ESTRATEGIAS TERAPEUTICAS. ANXARECU